Careers Contact Us Home About us Our Pipeline Our Science Partnering News & Events Home Novel T cell enhancing therapeutics in immuno-oncology News & Media 26 November 2021 Crescendo Biologics Wins “Best Established Biotech Company” at the 2021 OBN Awards View PDF 21 October 2021 Crescendo Biologics announces that Zai Lab has achieved proof-of-concept for ZL-1102 (Humabody®, CB001) in a Phase 1b clinical trial in psoriasis patients View PDF 20 October 2021 Crescendo Biologics announces prestigious new collaboration with The Institute of Cancer Research, London View PDF 20 May 2021 Crescendo Biologics announces initiation of Phase 1 study of CB307 in patients with advanced, PSMA-positive solid tumours Join our Mailing List Humabody® and Multibody® are registered trademarks of Crescendo Biologics Ltd. Meditrina Building 260, Babraham Research Campus, Cambridge, CB22 3AT Cambridge Web Design We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok